Semaglutide denied as not medically necessary by Cigna?
Most insurers reverse a medical-necessity denial when the appeal cites the specific clinical guideline (NCCN, ADA, AACE, etc.) that supports the requested treatment for your indication.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Cigna typically requires
Cigna's specific coverage criteria for semaglutide are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Cigna angle on Semaglutide
## Why Cigna May Deny Semaglutide for Medical Necessity
A medical-necessity denial from Cigna means the plan's reviewers concluded — based on the information submitted with the prior authorization request — that semaglutide has not been shown to be necessary for your specific clinical situation according to Cigna's medical policy criteria. Common gaps include incomplete documentation of diagnosis severity, missing evidence of prior treatment attempts, or a prescribing note that does not directly connect your clinical picture to the policy's coverage criteria.
## Why This Denial Is Appealable
Medical-necessity decisions are made on the documentation submitted, not on your actual clinical condition. A denial based on incomplete records is not a finding that semaglutide is unnecessary — it is a finding that necessity was not yet proven on paper. A strong appeal closes that evidentiary gap by providing structured, criterion-by-criterion documentation directly tied to Cigna's own published policy language.
## Your Federal Appeal Rights
- Internal appeal: Under ERISA §503 (employer-sponsored plans) or applicable state external-review law (individual and fully-insured plans), you are entitled to a full-and-fair internal review. The deadline to file is stated on your denial notice — do not miss it.
- External review: If the internal appeal is denied, ACA §2719 provides access to an independent review organization (IRO). The window to request external review is generally approximately four months from the date of the final internal denial; confirm the exact date on your denial letter.
- Expedited review: If waiting the standard timeline would seriously jeopardize your health or ability to function, request expedited processing for both the internal and external levels simultaneously.
## Documentation to Gather
1. Confirmed diagnosis: Chart notes, lab results, imaging, or specialist records that establish your diagnosis with objective clinical evidence, including date of diagnosis and severity. 2. Prior treatment history: A chronological list of all treatments previously tried for this condition — medication names (generic), start and stop dates, reason for discontinuation (lack of efficacy, side effects, contraindication), and prescriber documentation of each outcome. 3. Clinical severity documentation: Objective measures from your chart that reflect disease severity — the specific measures your prescriber uses, with dates, without relying on any specific numeric cutoff in this summary. 4. Prescriber medical-necessity letter: A detailed, signed letter from the treating physician specifically addressing Cigna's coverage criteria for semaglutide, explaining why each criterion is met for you. 5. Relevant specialist records: If a specialist (endocrinologist, cardiologist, obesity medicine specialist) is involved in your care, their records add significant weight.
## Criteria-Mapping Structure
Obtain Cigna's published medical policy for semaglutide (available on Cigna's provider or member portal). List every coverage criterion and provide a direct chart-based answer for each:
| Cigna Coverage Criterion (from policy) | Your Supporting Chart Evidence | |----------------------------------------|--------------------------------| | Confirmed diagnosis of [condition per policy] | [Date of diagnosis, diagnosing provider, objective findings] | | Prior treatment with [specified agent(s)] | [Drug name, dates of use, outcome, reason stopped] | | Prescriber attestation of clinical necessity | [Date of medical-necessity letter, prescriber name and specialty] | | Additional plan-specific criteria | [Corresponding chart fact for each] |
The goal is to leave no criterion unanswered. Every unanswered criterion is a reason for a second denial.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →